Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women

Paulo H. N. Harada; Julie E. Buring; Nancy R. Cook; Michael E. Cobble; Krishnaji R. Kulkarni; Samia Mora

Disclosures

J Endo Soc. 2017;1(2):113-123. 

In This Article

Conclusion

In this large population of apparently healthy women, individuals with SCH had differences in their biomarker profile that indicated worsening lipoprotein insulin resistance and higher cardiometabolic risk compared with euthyroid individuals, despite having similar LDL cholesterol and total cholesterol levels. These findings suggest that cardiometabolic risk may increase early in the progression toward SCH and overt HT.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....